April 21, 2026
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreJuly 24, 2026
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreJuly 09, 2026
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreJuly 24, 2026
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreSeptember 09, 2026
According to Payal Rabde, who specializes in the therapeutic area, emergency healthcare, and patient care, with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the operating room integration market. The global operating room integration market size was estimated at USD 2.3...
September 09, 2026
According to Payal Rabde, who specializes in healthcare services, emergency care systems, and healthcare market intelligence, with 4+ years of experience in market research and industry analysis. Her research indicates that the U.S. Emergency Department Market is set to grow from USD 229.25 billion in 2026 to USD 388.96 billion by 2035, driven by r...
September 08, 2026
Based on market forecasts, the global healthcare consulting services market, projected at USD 32.08 billion in 2025, is expected to reach USD 75.95 billion by 2034, growing at a CAGR of 10.05% over the forecast period. The healthcare consulting services market is expanding due to growing digital transformation as well as increasing adoption of an...
September 08, 2026
According to Payal Rabde, who specializes in mRNA synthesis, formulation, lipid nanoparticles, drug delivery, process development, analytical testing, GMP manufacturing scale-up, fill-finish, quality control, and mRNA therapeutics, with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth oppor...
September 08, 2026
Market insights predict, the drug discovery as a service industry is expected to grow from USD 24.32 billion in 2025 to USD 79.82 billion by 2034, driven by a CAGR of 14.17%. The drug discovery as a service market is expanding due to increasing cancer occurrence as well as growing drug discoveries for chronic diseases. North America led the market ...
September 07, 2026
According to market projections, the pharmaceutical testing services sector is expected to grow from USD 4.72 billion in 2025 to USD 12.86 billion by 2035, reflecting a CAGR of 10.54%.Due to accelerating heavy investments in R&D and demand for biologics, biosimilars are fueling the global market growth. In this global market, North America domi...
September 07, 2026
According to Payal Rabde, who specializes in protecting and delivering living cell therapy, regenerative medicine, and controlled therapeutic applications, with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the cell encapsulation market. The global cell encapsulation mar...
September 07, 2026
Payal Rabde is a Market Research Analyst specializing in the healthcare, pharmaceuticals, biotechnology, and life science market. She tracks increasing clinical activities, expanding retinal disease treatments, and new platform launches. Her research provides in-depth market intelligence, competitive analysis, and strategic insights to support ...
September 04, 2026
According to market projections, the surgical drapes & gown sector is expected to grow from USD 3.54 billion in 2025 to USD 5.78 billion by 2034, reflecting a CAGR of 5.64%. Generally, the market is driven by a rising geriatric population, the growing case of chronic conditions, and increasing cases of accidents and sports injuries. However, No...
September 04, 2026
Market insights predict, the veterinary CRO and CDMO industry is expected to grow from USD 7.77 billion in 2025 to USD 16.13 billion by 2034, driven by a CAGR of 8.43%. The market is growing due to rising pet ownership and increased focus on animal health. Pharma companies are outsourcing R&D and manufacturing to reduce costs and speed up produ...